It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Purpose: The purpose of this paper is to describe an alternative approach to telemonitoring patients suffering from Chronic Heart Failure (CHF), i.e. the Business-to-Consumer model (B2C), by extending the current Business-to-Business model (B2B). The B2C model is the one where the customer, in this case the patient, is the payer for the services consumed. We describe and perform an initial evaluation of the extension of the B2B to the B2C model for telemonitoring patients with CHF. Design/Methodology/Approach: We explored the problems in implementation of telemonitoring via the B2B model by means of a Root Cause Analysis, including the 5-whys method to help us understand the shortcomings of the B2B approach, and then the 5W1H method to explore whether the B2C is a better strategy. The extension of the model was executed in the Business Model Generation framework. By using qualitative content analysis techniques we supported our argumentation with findings from other studies. Findings: The B2C model is based on the interplay of four agents - Healthcare Provider, Equipment Manufacturer, Payer/Regulator and Distributor/Promotor - all working together to improve health related outcomes in a jurisdiction. The success of the extended model in telemonitoring CHF hinges on Telemonitoring Center and Telehealth Nurses being repositioned in the out-of-the hospital setting. Social implications: We believe that penetration of mobile telehealth via the B2C model will allow for greater availability, access and equity in healthcare for patients with CHF. Originality/Value: We introduced a fourth pillar to the existing B2B model, i.e. Distributors and/or Promotors. The B2C model we propose does not exist currently but might allow for scalability, generalizability and transferability of telemonitoring currently unattained with the B2B model.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Erasmus School of Health Policy and Management, Erasmus University Rotterdam; Professional Healthcare Services & Solutions, Philips Research
2 Department of Patient & Care, Maastricht UMC, The Netherlands; Department of Family Medicine and Chronic Care, Vrije Universiteit Brussels, Belgium; Panaxea b.v., Amsterdam, the Netherlands
3 Professional Healthcare Services & Solutions, Philips Research
4 Rotterdam School of Management, Erasmus University Rotterdam
5 Erasmus School of Health Policy and Management, Erasmus University Rotterdam; iMTA, Institute of Medical Technology Assessment, Erasmus University Rotterdam




